Immage Biotherapeutics Corp. (IMMG)
- Previous Close
0.0000 - Open
0.0000 - Bid --
- Ask --
- Day's Range
0.0000 - 0.0000 - 52 Week Range
0.0000 - 0.0000 - Volume
1,000 - Avg. Volume
896 - Market Cap (intraday)
151 - Beta (5Y Monthly) 75.12
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0120 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Immage Biotherapeutics Corp. does not have significant business operations. Previously, it was engaged in developing novel immunotherapy biologics to treat various cancers in the United States. The company was formerly known as Epicure Charcoal, Inc. and changed its name to Immage Biotherapeutics Corp. in June 2015. The company was founded in 2012 and is headquartered in Bethesda, Maryland. Immage Biotherapeutics Corp. is a subsidiary of Coventry International Limited.
www.immagebio.com3
Full Time Employees
August 31
Fiscal Year Ends
--
Sector
--
Industry
Related News
Performance Overview: IMMG
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: IMMG
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: IMMG
Valuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-496.11%
Return on Equity (ttm)
-1,133.57%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-1.83M
Diluted EPS (ttm)
-0.0120
Balance Sheet and Cash Flow
Total Cash (mrq)
53.69k
Total Debt/Equity (mrq)
251.83%
Levered Free Cash Flow (ttm)
-1.14M
Company Insights: IMMG
IMMG does not have Company Insights